CHASE WILLIAM J 4
4 · Intellia Therapeutics, Inc. · Filed Aug 22, 2025
Insider Transaction Report
Form 4
CHASE WILLIAM J
Director
Transactions
- Purchase
Common Stock
2025-08-20$10.03/sh+100,000$1,003,000→ 134,693 total
Footnotes (2)
- [F1]Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on August 20, 2025 at each separate price.